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Abstract 
Background: This study was investigated the effects of dexmedetomidine in combination with 
fentanyl-based intravenous patient-controlled analgesia (IV-PCA) on pain attenuation in patients 
undergoing open gastrectomy in comparison with conventional thoracic epidural patient-controlled 
analgesia (E-PCA) and IV-PCA.  
Methods: One hundred seventy-one patients who planned open gastrectomy were randomly 
distributed into one of the 3 groups: conventional thoracic E-PCA (E-PCA group, n = 57), 
dexmedetomidine in combination with fentanyl-based IV-PCA (dIV-PCA group, n = 57), or 
fentanyl-based IV-PCA only (IV-PCA group, n = 57). The primary outcome was the postoperative pain 
intensity (numerical rating scale) at 3 hours after surgery, and the secondary outcomes were the 
number of bolus deliveries and bolus attempts, and the number of patients who required additional 
rescue analgesics. Mean blood pressure, heart rate, and adverse effects were evaluated as well.  
Results: One hundred fifty-three patients were finally completed the study. The postoperative pain 
intensity was significantly lower in the dIV-PCA and E-PCA groups than in the IV-PCA group, but 
comparable between the dIV-PCA group and the E-PCA group. Patients in the dIV-PCA and E-PCA 
groups needed significantly fewer additional analgesic rescues between 6 and 24 hours after surgery, and 
had a significantly lower number of bolus attempts and bolus deliveries during the first 24 hours after 
surgery than those in the IV-PCA group.  
Conclusions: Dexmedetomidine in combination with fentanyl-based IV-PCA significantly improved 
postoperative analgesia in patients undergoing open gastrectomy without hemodynamic instability, 
which was comparable to thoracic E-PCA. Furthermore, this approach could be clinically more 
meaningful owing to its noninvasive nature. 
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Background 
Radical open gastrectomy is one of the major 
upper abdominal surgeries that have been reported to 
cause acute postoperative pain [1]. Moreover, the 
severity of pain is higher especially in this 
upper-abdominal surgery, which can lead to the 
impairment of the respiratory effort due to the 
restriction of the movement of the thoracic cage and 
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abdomen, as well as the decreased respiratory 
capacity [2, 3]. Such changes have a negative impact 
on the course of postoperative recovery [4]. 
Conventionally, pain after open gastrectomy has 
been controlled with thoracic epidural 
patient-controlled analgesia (E-PCA) or intravenous 
PCA (IV-PCA) [1, 4]. Thoracic E-PCA has an excellent 
effect in controlling postoperative pain, when 
properly positioned [1, 5-7]. However, as it is a 
relatively invasive technique, its application is limited 
by specific contraindications such as infection or 
bleeding tendency, and there is a possibility of 
malpositioning of the catheter in the spinal nerve 
roots leading to severe postoperative neurologic 
deficits due to ischemia of the sensory and motor 
nerves [5, 7-10]. Therefore, despite its potential 
benefits, the clinical use of E-PCA may have even 
declined because of these types of complications [1, 
11].  
In case of IV-PCA, higher doses of opioids are 
required to control postoperative pain effectively; 
however, this often leads to the discontinuation of 
IV-PCA because of persistent adverse effects such as 
nausea, vomiting, and pruritus [1, 12, 13]. 
Dexmedetomidine is well recognized as an 
extremely preferential α2-receptor agonist that has 
sedative and analgesic effects without unfavorable 
respiratory suppression [14-16]. Previous studies have 
reported that dexmedetomidine administration 
during surgery could reduce the amounts of opioids 
and analgesics used after surgery [17-20]. 
Furthermore, current studies on the combination of 
dexmedetomidine with various opioid-based IV-PCA 
techniques have demonstrated that this combination 
treatment could help provide better analgesia and 
opioid-sparing effects without any remarkable 
unfavorable effects [21-24]. 
Hence, in this prospective, randomized clinical 
trial, we investigated the effects of dexmedetomidine 
in combination with fentanyl-based IV-PCA on pain 
attenuation in patients undergoing open gastrectomy 
in comparison with conventional thoracic E-PCA and 
IV-PCA.  
Materials and Methods 
Study population 
This investigation was approved from the 
Institutional Review Board and Hospital Research 
Ethics Committee of Severance Hospital (Yonsei 
University Health System in Seoul, Korea; IRB 
protocol No. 4-2014-0883), and consequently 
registered at http://clinicaltrials.gov (registration No. 
NCT02325882). After acquiring written informed 
consent from all patients, 171 patients with stomach 
cancer, of age 20 to 65 years and American Society of 
Anesthesiologists physical status I/II, who were 
planned to undergo elective conventional open 
gastrectomy, were enrolled between July, 2015 and 
March, 2016. The exclusion criteria were as follows: 
refusal of PCA application; histories of abdominal 
surgery; prior cardiac disease including unstable 
angina, congestive heart failure, uncontrolled 
hypertension; concomitant coagulopathy; presence of 
vertebral deformity or disease; concomitant 
pulmonary, renal, or hepatic disease; any 
contraindication to epidural catheterization; any 
allergy or hypersensitivity to fentanyl, α2-adrenergic 
agonists, or local anesthetics; use of any type of 
chronic pain killer or current opioid; cognitive, 
neurological, or psychiatric impairment; and 
incapability to report the pain intensity on the pain 
scale. All enrolled patients were educated on how to 
express the intensity of pain by using the numerical 
rating scale (NRS; 0, no pain, and 10, worst pain 
possible) [25], and on how to use the PCA machine in 
the preanesthetic room.  
Randomization and Perioperative Protocol 
The assignments of the patients were performed 
randomly into one of 3 groups (1:1:1) according to 
preset random numbers by using a 
computer-generated table (http://www.random.org) 
with no dividing blocks and stratification: 
conventional thoracic E-PCA (E-PCA group, n = 57), 
dexmedetomidine in combination with 
fentanyl-based IV-PCA (dIV-PCA group, n = 57), or 
fentanyl-based IV-PCA only (IV-PCA group, n = 57). 
In the E-PCA group, the procedure for epidural 
catheter insertion was completed before the induction 
of general anesthesia. After standard monitoring, a 
single investigator performed the epidural 
catheterization at the level of T7–8 or T8–9 by using a 
17-gauge Tuohy needle, and a catheter was advanced 
5 cm into the epidural space. Intravascular or 
subarachnoid placement of the epidural catheter was 
excluded by checking the absence of aspirated blood 
or cerebrospinal fluid. Furthermore, intrathecal 
delivery of the local anesthetic was ruled out by 
confirming that no rapid onset of neuroaxial block 
was developed after the administration of 3 mL of 1% 
lidocaine. Upon the initiation of peritoneal closure, 
the PCA machine (Accumate 1100®; Woo Young 
Medical Co., Ltd., Seoul, Korea) was started after 5 
mL of 0.15% ropivacaine was administered via the 
epidural catheter. The PCA regimen was a mixture of 
0.15% ropivacaine and 3 µg/mL of fentanyl in 0.9% 
normal saline solution with a total volume of 250 mL. 
All PCA machines for the 3 groups were programmed 
to deliver at the rate of 5 mL/h with a 0.5 mL per 
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demand allowed every 15-minute lockout time.  
In the IV-PCA group, after 1 µg/kg of fentanyl 
was administered intravenously at the start of 
peritoneal closure, PCA machine was applied 
intravenously, which consisted 15 µg/kg of fentanyl 
and 0.3 mg of ramosetron (Nasea, Astellas, Tokuo, 
Japan), mixed with 0.9% normal saline solution to a 
total volume of 250 mL. Thus, in the IV-PCA group, 
fentanyl was infused basally at a rate of 0.3 µg/kg/ h 
with a bolus dose of 0.03 µg/kg and a lockout time of 
15-min.  
In the dIV-PCA group, dexmedetomidine (100 
μg/mL at 2 mL/vial; Hospira Worldwide, Seoul, 
Korea) was infused continuously at a rate of 0.1 
µg/kg/ h from anesthetic induction until the start of 
peritoneal closure. Subsequently, the PCA, containing 
dexmedetomidine in addition to the fentanyl and 
ramosetron like in the IV-PCA group, was applied 
intravenously. Thus, in the dIV-PCA group, the 
background infusion rate of dexmedetomidine was 
0.07µg/kg/ h with a bolus dose of 0.007 µg/kg, and 
that of fentanyl was 0.3µg/kg/ h with a bolus dose of 
0.03 µg/kg allowed every 15-min lockout time. In all 
three groups, the agents for PCA and the study drug 
were prepared by an investigator who was not 
involved in the assessment of postoperative pain 
intensity.  
Anesthesia 
Anesthesia was accomplished along with the 
same standard protocol in all three groups. After the 
patient arrived in the operating room, premedication 
was done with 0.1 mg of glycopyrrolate administered 
intravenously. All patients were applied with 
noninvasive arterial blood pressure monitoring 
device for mean blood pressure (MBP) measurement, 
electrocardiogram (ECG) for heart rate (HR) 
monitoring, oxygen saturation (SpO2) measurement 
device, and bispectral index (BIS) monitor (Aspect 
A-2000®; Aspect Medical System Inc., Newton, MA, 
USA). Anesthesia was induced with 1.5 mg/kg of 
propofol, 0.5 μg/kg of remifentanil, and 1.2 mg/kg of 
rocuronium. Thereafter, mechanical ventilation was 
kept to maintain the end-tidal carbon dioxide at 30–40 
mm Hg in 50% O2/air throughout the surgery. 
Anesthesia was maintained with 0.6–1.2 age-adjusted 
minimal alveolar concentration end-tidal sevoflurane 
and 0.02–0.2 µg/kg/min of remifentanil, which were 
adjusted according to stable hemodynamic variables, 
including MBP or HR maintained within 20% of the 
baseline and BIS scores between 40 and 60. 
Hypotension [MBP <60 mm Hg or systolic blood 
pressure (SBP) <90 mm Hg] was managed with fluid 
loading at 100 mL increments or intravenous 
ephedrine at 4 mg increments, and 0.25 mg 
intravenous atropine was used to manage 
bradycardia (HR <40 beats/min). For the prevention 
of postoperative nausea and vomiting (PONV), 0.3 
mg of ramosetron was administered at the start of 
peritoneal closure, and naloxone and oxygen were 
prepared for the event of respiratory depression. In 
case of the development of persistent complications 
such as severe PONV, hypotension, bradycardia, and 
respiratory depression despite of appropriate 
treatment, applications with the PCA machine were 
discontinued. 
Data Collection  
When the patients were transferred to the 
postanesthesia care unit (PACU) after surgery, they 
were reinstructed about the use of the PCA machine. 
Thereafter, recovery nurses who were not involved in 
this study assessed the resting NRS scores at 0.5 h and 
encouraged the patients to push the bolus button 
whenever they feel pain at a resting NRS score of >3. 
For patients who showed poor response to the PCA, 
thus felt sustained pain at a resting NRS score of >4, 
additional rescue analgesics with pethidine at 12.5 mg 
increments were given. After PACU discharge, 
postoperative pain assessment was performed at 1, 2, 
3, 6, 12, 18, 24, and 36 h after surgery by the attending 
nurses of the Postoperative PCA Management 
Services of our institution, who were not aware of the 
purpose of this study. Similarly, for patients who 
experienced sustained pain at a resting NRS score of 
>4 in the admission room, additional rescue 
analgesics of pethidine at 12.5 mg increments were 
also administered. After finishing the infusion of 
PCA, the machine was taken off and sent to the 
anesthesiology department for the evaluation of all 
records in relation to the deliveries and attempts with 
the bolus button. In addition to the records of the PCA 
machine, the number of patients who required 
additional rescue analgesics was also noted. MBP and 
HR data were collected at baseline; at PACU arrival; 
and at 0.5, 1, 2, 3, 6, 12, 18, 24, and 36 h after surgery. 
The level of sedation (assessed on a 5-point scale—0, 
fully awake; 1, drowsy/closed eyes; 2, asleep/easily 
aroused with light tactile stimulation or a simple 
verbal command; 3, asleep/arousable only with 
strong physical stimulation; and 4, unarousable) was 
assessed as well.  
Statistical Analysis 
On the basis of a preliminary study, the mean ± 
standard deviation (SD) of the resting NRS score at 3 h 
after surgery in the IV-PCA group was 5.35, and the 
corresponding value for the E-PCA group was 4.38. In 
order to detect an expected difference of 1 with a SD 
of 1.8 for the resting NRS score in the dIV-PCA, the 
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obtained sample size in each group was 51 patients 
with α = 0.05 and β = 0.8. Assuming a possible 
dropout rate of 10%, 57 patients were determined to 
be required in each group.  
Statistical analyses were performed by using 
SAS software version 9.2 (SAS Inc., Cary, NC, USA) 
and IBM SPSS Statistics 20 (SPSS Inc., Chicago, IL, 
USA). All values were shown as mean ± SD, number 
of patients (proportion), or median (range). One-way 
analysis of variance was performed to analyze all 
parametric variables among the three groups, and 
nonparametric data were analyzed by using the 
Kruskal-Wallis test. For categorical data, the 
Chi-square test or Fisher’s exact test was used in the 
analysis when applicable. A linear mixed model was 
used in the analysis for repeated-measure variables 
such as NRS, MBP, and HR. Post-hoc analyses with 
Bonferroni correction were applied when the 
interaction of group, time, and group by time showed 
statistical significance. A P value of <0.05 was taken to 
indicate statistical significance. 
Results 
Of 190 patients evaluated for eligibility, 171 
patients were initially registered and assigned into the 
3 groups. Ten patients in the E-PCA group were 
eliminated because PCA was discontinued owing to 
persistent hypotension. In the dIV-PCA group, 3 
patients were excluded from the analysis for the 
following reasons: one patient did not receive the 
allocated intervention because of another surgery, one 
patient discontinued PCA because of persistent 
dizziness, and one patient had deleted PCA data due 
to a mechanical problem of the PCA machine. Five 
patients in the IV-PCA group were removed from the 
analysis for the following reasons: one patient did not 
receive the allocated intervention because of another 
surgery, three patients discontinued PCA because of 
persistent nausea, and one patient had deleted PCA 
data due to a mechanical problem of the PCA 
machine. The remaining 153 patients successfully 
completed the study without any complications 
(Figure 1).  
The demographic and intraoperative variables 
were shown (Table 1). Apart from the total 
administered dose of remifentanil and ephedrine, 
there were no significant differences among the 3 
groups. The total administered dose of remifentanil 
was higher in the IV-PCA group than in the E-PCA 
and dIV-PCA groups (Bonferroni corrected P = 0.017 
and P < 0.001, respectively). In addition, the patients 
in the E-PCA group required more ephedrine than 
those in the IV-PCA group (8.4 ± 9.1 vs. 4.0 ± 4.8 μg; 
Bonferroni corrected P = 0.013).  
 
 
Figure 1. Consort flow diagram. E-PCA, epidural patient-controlled analgesia; dIV-PCA, dexmedetomidine in combination with fentanyl-based intravenous 
patient-controlled analgesia; IV-PCA, intravenous patient-controlled analgesia; SBP, systolic blood pressure; PONV, postoperative nausea and vomiting. 
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The pain scores at rest were shown in Figure 2. 
Postoperative pain intensity was significantly lower 
in the dIV-PCA and E-PCA groups than in the 
IV-PCA group, however, it was comparable between 
the dIV-PCA group and the E-PCA group. After 
post-hoc analysis with Bonferroni corrections, the 
NRS scores for resting pain in the dIV-PCA group 
were lower than those in the IV-PCA group at all time 
points during the 36 h after surgery (P < 0.01, 
Bonferroni corrected), and the E-PCA group showed 
lower NSR scores than those in the IV-PCA group at 
0.5, 2, 3, 6, 12, 18, 24, and 36 h after surgery (P < 0.01, 
Bonferroni corrected). Moreover, patients of the 
dIV-PCA group required significantly fewer 
additional analgesic rescues than did patients of the 
IV-PCA group between 2 and 24 h after surgery, and 
patients in the E-PCA group needed significantly 
fewer additional analgesic rescues than those in the 
IV-PCA group between 6 and 24 h after surgery 
(Table 2). Figure 3 showed the number of bolus 
attempts and the number of successful bolus 
deliveries during the first 36 h after surgery. Patients 
in the dIV-PCA and E-PCA groups had a significantly 
lower number of bolus attempts and bolus deliveries 
than those in the IV-PCA group during the first 24 h 
after surgery (both P < 0.05, Bonferroni corrected).  
Significant differences in MBP and HR were 
observed among groups in the linear mixed model 
analysis (P = 0.007 and P < 0.001, respectively) (Figure 
4). MBP in the E-PCA group was lower than that in 
the IV-PCA group at 3, 12, and 18 h after surgery, 
although more ephedrine was administered in the 
E-PCA group than in the IV-PCA group (P = 0.023, 
0.010, and 0.033, respectively; Bonferroni corrected). 
Furthermore, patients in the dIV-PCA group showed 
lower MBP than those in the IV-PCA group at 1, 3, 6, 
12, 18, 24, and 36 h after surgery (P < 0.05, Bonferroni 
corrected). HR was lower in the dIV-PCA group than 
in the E-PCA group at 2, 3, and 6 h after surgery (P = 
0.02, 0.01, and 0.02, respectively; Bonferroni 
corrected). However, no patient in either group 
required atropine administration. The other 
postoperative adverse effects were not significantly 
different among the 3 groups (P > 0.05; Table 3). In 
addition, there were no patients who exhibited 
respiratory depression. 
 
Table 2. Number of Patients Who Needed Additional Rescue 
Analgesics (Pethidine) During 36 h After Surgery 
Interval E-PCA group  
(n = 47) 
dIV-PCA group  
(n = 54) 
IV- PCA group  
(n = 52) 
P 
value 
0 - 2 h 16 (34%) 22 (41%) 28 (54%) 0.054 
2 - 6 h 12 (26%) 10 (19%)* 23(44%) 0.012 
6 - 12 h 9 (19%)† 8 (15%)* 24(46%) <0.001 
12 - 24 h 12 (26%)† 12 (22%)* 33(63%) <0.001 
24 - 36 h 6 (13%) 4 (7%) 10 (19%) 0.199 
Data are presented as number of patients (proportion).  
† P <0.01, vs. IV-PCA group (Bonferroni corrected), * P <0.01 vs. IV-PCA group 
(Bonferroni corrected)  
 
 
Table 3. Postoperative Adverse Effects 
 E-PCA  
(n = 47) 
dIV-PCA  
(n = 54) 
IV- PCA  
(n = 52) 
P value 
Sedation scores 0(0-0) 0(0-1) 0(0-1) 0.41 
Nausea 5 6 7 0.904 
Dizziness 1 4 3 0.594 
Headache 1 3 2 0.056 
Hypotensive episode  4 3 1 0.354 
Urinary retention  7 5 5 0.653 
Data are presented as median (interquartile range) or number of patients. Level of 
sedation; 0 = fully awake, 1= drowsy/closed eyes, 2 = asleep/easily aroused with 
light tactile stimulation or a simple verbal command, 3 = asleep/arousable only by 
strong physical stimulation, and 4 = unarousable. 
 
 
Table 1. Patient Characteristics and Intraoperative Variables 
 E-PCA group  
(n = 47) 
dIV-PCA group  
(n = 54) 
IV- PCA group 
(n = 52) 
P value 
Age, years 58 ± 12 59 ± 7 62 ± 13 0.148 
Height, cm 167 ± 9 164 ± 8 163 ± 8 0.110 
Weight, kg 64 ± 11 62 ± 9 61 ± 12 0.558 
ASA physical status, I/II 18/29 23/31 20/32 0.895 
Hypertension 17 (36%) 19 (35%) 20 (39%) 0.955 
Diabetes mellitus 3 (6%) 5 (9%) 6 (12%) 0.686 
Female gender 16 (34%) 20 (37%) 20 (39%) 0.892 
Subtotal/Total 32/15 36/18 35/17 1.000 
Duration of surgery, min 179 ± 41 170 ± 32 178 ± 43 0.500 
Fluid intake, mL 1743 ± 468 1717 ± 489 1795 ± 744 0.783 
Blood loss, mL 223 ± 145 213 ± 182 231 ± 166 0.859 
Urine output, mL 241 ± 118 238 ± 171 276 ± 198 0.450 
Administered dose of remifentanil, μg 814 ± 280† 660 ± 260* 1000 ± 400 <0.001 
Administered dose of ephedrine, mg 8.4 ± 9.1‡ 6.3 ± 7.5 4.0 ± 4.8 0.016 
Data are presented as mean ± standard deviation or number of patients (proportion). ASA = American Society of Anesthesiologist, Subtotal = subtotal gastrectomy, Total = 
total gastrectomy.  
† P = 0.017, vs. IV-PCA group (Bonferroni corrected), * P <0.001, vs. IV-PCA group (Bonferroni corrected), ‡ P = 0.013, vs. IV-PCA group (Bonferroni corrected). 
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Figure 2. Pain score at rest during the first 36 h after surgery. Data are expressed as mean ± standard deviation. †P < 0.001, ††P < 0.01 vs. the IV-PCA group 
(Bonferroni corrected); *P < 0.001, **P < 0.01 vs. the IV-PCA group (Bonferroni corrected). E-PCA, epidural patient-controlled analgesia; dIV-PCA, 
dexmedetomidine in combination with fentanyl-based intravenous patient-controlled analgesia; IV-PCA, intravenous patient-controlled analgesia; NRS, numerical 
rating scale. 
 
Figure 3. Number of bolus deliveries (A) and the number of bolus attempts (B) during the first 36 h after surgery. Data are expressed as mean ± 
standard deviation. †P < 0.01, ††P < 0.05 vs. the IV-PCA group (Bonferroni corrected); *P < 0.01, **P < 0.05 vs. the IV-PCA group (Bonferroni corrected). E-PCA, 
epidural patient-controlled analgesia; dIV-PCA, dexmedetomidine in combination with fentanyl-based intravenous patient-controlled analgesia; IV-PCA, intravenous 
patient-controlled analgesia 
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Figure 4. Mean blood pressure (A) and heart rate (B) from prior induction until 36 h after surgery. Data are expressed as mean ± standard deviation. 
*P < 0.05, †P < 0.05 vs. the IV-PCA group (Bonferroni corrected); ‡P < 0.05 vs. the E-PCA group (Bonferroni corrected). E-PCA, epidural patient-controlled analgesia; 
dIV-PCA, dexmedetomidine in combination with fentanyl-based intravenous patient-controlled analgesia; IV-PCA, intravenous patient-controlled analgesia; Baseline, 
before induction of anesthesia; PACU, on arrival of post-anesthetic care unit. 
 
Discussion 
This prospective randomized study 
demonstrated that for patients undergoing open 
gastrectomy, dexmedetomidine in combination with 
fentanyl-based IV-PCA significantly improved 
postoperative analgesia than fentanyl-based IV-PCA, 
which was comparable to thoracic E-PCA. 
Furthermore, such improved effects could be 
achieved without hemodynamic instability by using 
this dexmedetomidine-fentanyl combination as a 
noninvasive treatment. 
It is generally recognized that intense pain 
occurring during the postoperative period may have a 
major impact on the postoperative clinical outcomes. 
Insufficient analgesia might cause psychological 
distress as well as physical impairment, several 
postoperative complications, and even progression to 
chronic pain [2, 26]. Especially, pain after the major 
abdominal surgery such as open gastrectomy could 
lead to restriction of thoracic and abdominal 
respiration as well as attenuation of vital capacity and 
tidal volume breathing, which probably have adverse 
effects on the respiratory drive [27, 28]. In addition, it 
may result in significant cardiovascular changes, 
cognitive impairment, delayed recovery of bowel 
motility, and neuroendocrine instability, which will 
most likely have a deleterious effect on the 
postoperative recovery process [4]. Thus, 
postoperative pain management concomitant with 
maintenance of hemodynamic stability is very crucial.  
In the last few decades, thoracic E-PCA and 
IV-PCA have been generally used for postoperative 
analgesia in patients after open gastrectomy [1, 4]. 
Several studies have reported that thoracic E-PCA is 
considered more effective than IV-PCA in relieving 
postoperative pain [4, 29, 30]. Furthermore, current 
research indicates that thoracic E-PCA is considered 
the “golden” standard in the management of pain 
after the major upper abdominal surgery, owing to its 
excellent analgesic effects [1, 5-7]. However, it is a 
relatively invasive technique and its application is 
limited by specific contraindications such as infection 
or bleeding tendency [7]. In addition to these 
limitations, there is a possibility of several 
complications such as hematoma, or severe 
postoperative neurologic deficits resulting from 
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malpositioning of the catheter in the spinal nerve 
roots [8, 9]. Therefore, despite its potential benefits, 
the clinical use of E-PCA may have even declined 
because of these types of complications [1, 11].  
IV-PCA requires a higher dose of opioids in 
order to acquire satisfactory analgesic effects. This, in 
turn, produces adverse effects such as nausea, 
vomiting and pruritus, which causes patients to 
discontinue the use of intravenous PCA [1, 12, 13]. 
Indeed, in the present study, 3 patients in the IV-PCA 
group chose to discontinue the use of PCA because of 
persistent PONV. For postoperative recovery, it is 
very crucial to amplify pain relief without increasing 
the adverse effects of analgesics. The multimodal 
analgesic approach, which involves using analgesics 
with different action mechanisms, might be a good 
strategy in the current setting [31, 32]. Of the various 
available multimodal protocols, the combination of an 
opioid with one or more adjunctive drugs, such as 
nonsteroidal anti-inflammatory agents, pure opioid 
antagonists, and ketamine, has been considered the 
expedient option for IV-PCA in current postoperative 
pain management [33-35].  
Dexmedetomidine, an extremely selective 
α2-adrenergic agonist that has hypnotic, sedative, and 
analgesic actions and generates sympatholytic 
responses, does not cause unfavorable respiratory 
suppression [14-16]. Currently, it has been suggested 
that combination treatment with dexmedetomidine 
and opioid-based IV-PCA could provide better 
analgesic and opioid-sparing effects without any 
remarkable detrimental influences [21-24]. However, 
to the best of our knowledge, no prior studies have 
investigated the impact of dexmedetomidine in 
combination with fentanyl-based IV-PCA on the 
attenuation of postoperative pain intensity in 
comparison with thoracic E-PCA and IV-PCA.  
In the present study, we found significantly 
reduced resting NRS scores in the dIV-PCA group 
compared with those in the IV-PCA group during the 
first 36 h after surgery, although the number of bolus 
deliveries and attempts was significantly lower in the 
dIV-PCA group than in the IV-PCA group for the first 
24 h after surgery; this finding was in accordance with 
those of previous reports [21-24]. Moreover, patients 
in the dIV-PCA group required significantly fewer 
additional rescue analgesics during 2–6, 6–12, and 
12–24 h after surgery than those in the IV-PCA group 
(*P = 0.004, P < 0.001, P < 0.001, respectively; 
Bonferroni corrected). In the dIV-PCA group in 
comparison with the E-PCA group, comparable 
analgesic effects were achieved. A tendency was 
shown that the number of bolus deliveries and 
attempts were lower in patients of the E-PCA group 
than those in patients of the dIV-PCA group; 
however, no statistical difference was observed after 
post-hoc analysis with Bonferroni correction. 
Epidural-induced hypotension is also very 
common, which is partly due to cardio-depressant 
activity and arteriovenous vasodilation [7, 36, 37]. In 
the present study, persistent hypotension (SBP <90 
mm Hg) developed in 10 patients of the E-PCA group. 
Consequently, these patients were excluded because 
of the discontinuation of use of the PCA machine 
(Figure 1). Except for the 10 patients who were 
dropped from the E-PCA group, none of the patients 
in all groups developed severe hemodynamic 
instability (SBP <90 mm Hg, MBP <60 mm Hg). 
Previous trials have been conducted with various 
dosages for an infusion rate of dexmedetomidine in 
PCA mixture from 0.02 to 0.6 µg/kg/ h within the 
range of the recommended dose by the manufacturer 
(0.2–0.7 µg/kg/ h) [21-24, 38]. In the present study, we 
selected 0.07 µg/kg/ h as the infusion dose and 
0.007µg/kg/ h as the bolus dose with a maximum 
limit of 0.1µg/kg/ h in order to acquire the 
postoperative analgesic effect concomitant with 
maintaining hemodynamic stability. MBP in the 
dIV-PCA group were significantly lower than those in 
the IV-PCA group at 1 and 3–36 h after surgery; 
however, at all time points, the MBP in the dIV-PCA 
group were >65 mm Hg. The patient who showed the 
lowest MBP was in the E-PCA group, which was 61 
mmHg. Furthermore, 4 patients in the E-PCA group 
and 3 patients in the dIV-PCA group developed 
intermittent mild hypotension (SBP <100 mm Hg), 
with no statistical difference. Moreover, no 
bradycardia (HR <40 beats/min) that had to be 
treated with atropine occurred in all of the 3 groups. 
Thus, these study findings may have clinical 
implication, considering that low dose of 
dexmedetomidine-fentanyl combination significantly 
improved postoperative analgesia while maintaining 
stable hemodynamics; especially for those patients 
who have limitations in applying the E-PCA.  
In addition, no significant difference was 
detected in postoperative adverse effects among the 3 
groups (P > 0.05). The incidence of PONV in our trials 
was not consistent with the findings of previous 
reports [21, 38]. This discrepancy might be derived 
from the low doses of dexmedetomidine (infusion 
rate, 0.07 µg/kg/ h; bolus rate, 0.007 µg/kg/ h; 
maximum limit, 0.1 µg/kg/ h) used in this study. 
Moreover, it might also be attributed to the removal of 
3 patients from the IV-PCA group because of 
persistent PONV.  
This study has several limitations. First, the 
patients received three different PCA regimens via 
different routes in accordance with the group 
allocation. However, we did not control this 
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confounding factor because the objective of our study 
was to investigate the effect of dexmedetomidine in 
combination with IV-PCA on pain intensity compared 
with the standard methods and regimens of PCA. 
Second, it still needs to be clarified whether the effects 
of dexmedetomidine in combination with IV-PCA on 
pain attenuation, compared with those of E-PCA, are 
dose dependent. In addition, more long-term 
follow-up data are required to evaluate the effects of 
dexmedetomidine-opioid combination on 
postoperative outcomes, including chronic pain. 
Thus, further investigations are imperative. Third, we 
included patients with a wide age range (20 to 65 
years), who underwent two types of surgeries 
(subtotal or total gastrectomy). Although the extent of 
postoperative pain intensity varies depending on the 
age, sex, and type of surgeries, the similar 
demographic variables among the 3 groups in the 
present study may have helped in preventing these 
variables from affecting the results of this study. 
Finally, it is uncertain whether the effects of 
dexmedetomidine on the attenuation of pain intensity 
were due to analgesic effect of itself or an indirect 
effect that decrease the remifentanil-induced 
hyperalgesia by reducing intraoperative remifentanil 
amounts. Therefore, more studies performed in 
regard to various setting would be needed.  
Conclusions 
Dexmedetomidine in combination with 
fentanyl-based IV-PCA significantly improved 
postoperative analgesia in patients undergoing open 
gastrectomy than fentanyl-based IV-PCA alone, 
comparable to thoracic E-PCA. Such improved effects 
could be achieved without hemodynamic instability; 
furthermore, this approach could be clinically more 
meaningful owing to its noninvasive nature.  
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